Q4 2017 Holdings
Filed 2018-02-14 | 6 holdings | $75.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma Ltd.(URGN) | Common Stock | M96088105 | $40.8K | 1,096,024 | 54.2% |
| Mersana Therapeutics, Inc. | Common Stock | 59045L106 | $15.7K | 955,709 | 20.9% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common Stock | 00847L100 | $13.6K | 5,062,363 | 18.1% |
| Immune Design Corp. | Common Stock | 45252L103 | $4.8K | 1,236,394 | 6.4% |
| Eagle Pharmaceuticals, Inc.(EGRX) | Common Stock | 269796108 | $362 | 6,777 | 0.5% |